Icon

ONYDA XR - (0.1MG/1ML)

CLONIDINE HYDROCHLORIDE None
0.1MG/1ML
Less Than $1000 mn
None None
None None
None None
ONYDA XR is a centrally acting alpha2-adrenergic agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy or as adjunctive therapy to central nervous system (CNS) stimulant medications in pediatric patients 6 years of age and older.
Yes
ONYDA XR Patent 1 Patent 2
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.